Stryker Yönetim

Yönetim kriter kontrolleri 3/4

Stryker CEO'su Kevin Lobo, Oct2012 tarihinde atandı, in görev süresi 12.08 yıldır. in toplam yıllık tazminatı $ 20.77M olup, şirket hissesi ve opsiyonları dahil olmak üzere 6.7% maaş ve 93.3% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.026% ine doğrudan sahiptir ve bu hisseler $ 38.76M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 6.2 yıl ve 6.5 yıldır.

Anahtar bilgiler

Kevin Lobo

İcra Kurulu Başkanı

US$20.8m

Toplam tazminat

CEO maaş yüzdesi	6.7%
CEO görev süresi	12.1yrs
CEO sahipliği	0.03%
Yönetim ortalama görev süresi	6.2yrs
Yönetim Kurulu ortalama görev süresi	6.5yrs

Son yönetim güncellemeleri

Recent updates

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Aug 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Aug 10

Stryker: Wait For A Better Entry Point Post-Q2 Results

Aug 06

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

Jul 11

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Jun 30

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

Jun 19

The Returns At Stryker (NYSE:SYK) Aren't Growing

Jun 16

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Jun 05

Stryker: Margin Gains Should Drive Upside

May 31

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

May 25

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

May 14

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

May 02

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Apr 29

Stryker: A Great Company At An Expensive Price

Apr 05

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Mar 26

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Mar 25

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26

CEO Tazminat Analizi

Kevin Lobo'un ücretlendirmesi Stryker'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	US$4b
Jun 30 2024	n/a	n/a	US$3b
Mar 31 2024	n/a	n/a	US$3b
Dec 31 2023	US$21m	US$1m	US$3b
Sep 30 2023	n/a	n/a	US$3b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$3b
Dec 31 2022	US$19m	US$1m	US$2b
Sep 30 2022	n/a	n/a	US$2b
Jun 30 2022	n/a	n/a	US$2b
Mar 31 2022	n/a	n/a	US$2b
Dec 31 2021	US$16m	US$1m	US$2b
Sep 30 2021	n/a	n/a	US$2b
Jun 30 2021	n/a	n/a	US$2b
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	US$13m	US$1m	US$2b
Sep 30 2020	n/a	n/a	US$2b
Jun 30 2020	n/a	n/a	US$2b
Mar 31 2020	n/a	n/a	US$2b
Dec 31 2019	US$15m	US$1m	US$2b
Sep 30 2019	n/a	n/a	US$3b
Jun 30 2019	n/a	n/a	US$4b
Mar 31 2019	n/a	n/a	US$4b
Dec 31 2018	US$14m	US$1m	US$4b
Sep 30 2018	n/a	n/a	US$1b
Jun 30 2018	n/a	n/a	US$1b
Mar 31 2018	n/a	n/a	US$1b
Dec 31 2017	US$14m	US$1m	US$1b

Tazminat ve Piyasa: Kevin 'nin toplam tazminatı ($USD 20.77M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 12.67M ).

Tazminat ve Kazançlar: Kevin 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Kevin Lobo (59 yo)

12.1yrs

Görev süresi

US$20,767,847

Tazminat

Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kevin Lobo	Chairman	12.1yrs	US$20.77m	0.026% $ 38.8m
Glenn Boehnlein	VP & CFO	8.6yrs	US$6.84m	0.0015% $ 2.3m
Viju Menon	Group President of Global Quality & Operations	6.6yrs	US$4.47m	0.0024% $ 3.6m
J. Pierce	Group President of MedSurg & Neurotechnology	6.3yrs	US$6.49m	0.015% $ 22.4m
Spencer Stiles	Group President of Orthopaedics & Spine	6.3yrs	US$6.49m	0.014% $ 20.1m
William Berry	VP & Chief Accounting Officer	3.3yrs	Veri yok	0.00078% $ 1.1m
Robert Cohen	CTO and VP of Global R&D - Joint Replacement	no data	Veri yok	Veri yok
Alan Douville	VP, Chief Information Officer & Chief Information Security Officer	6.2yrs	Veri yok	Veri yok
Jason Beach	Vice President of Finance & Investor Relations	2.3yrs	Veri yok	Veri yok
Robert Fletcher	VP & Chief Legal Officer	5.6yrs	US$2.24m	0.0024% $ 3.6m
Dana McMahon	VP & Chief Compliance Officer	no data	Veri yok	Veri yok
Yin Becker	VP of Communications	5.9yrs	Veri yok	0.0087% $ 12.7m

6.2yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim: SYK 'un yönetim ekibi deneyimli ve deneyimlidir ( 6.2 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kevin Lobo	Chairman	12.1yrs	US$20.77m	0.026% $ 38.8m
Lisa Skeete Tatum	Independent Director	4.5yrs	US$319.25k	0.00085% $ 1.2m
Howard Cox	Director Emeritus	6.5yrs	US$38.86k	Veri yok
John Brown	Chairman Emeritus	no data	US$286.99k	5.26% $ 7.7b
Ronda Stryker	Independent Director	40.8yrs	US$319.25k	4.77% $ 7.0b
Mary Brainerd	Independent Director	7.3yrs	US$334.25k	0.0015% $ 2.2m
Allan Golston	Independent Director	13.8yrs	US$334.25k	0.0039% $ 5.7m
Sherilyn S. McCoy	Lead Independent Director	6.5yrs	US$359.25k	0.00022% $ 322.8k
Rajeev Suri	Independent Director	6.5yrs	US$319.25k	0.0014% $ 2.0m
Giovanni Caforio	Independent Director	3.9yrs	US$319.25k	0.00067% $ 983.0k
Andrew Silvernail	Independent Director	11yrs	US$339.25k	0.0015% $ 2.1m
Rachel Ruggeri	Independent Director	less than a year	Veri yok	0.000010% $ 14.7k

6.5yrs

Ortalama Görev Süresi

59yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SYK 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.5 yıldır).

Stryker Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Chairman exercised options and sold US$43m worth of stock

Independent Director recently sold US$84m worth of stock

Independent Director notifies of intention to sell stock

Independent Director notifies of intention to sell stock

VP & CFO recently sold US$6.7m worth of stock

VP & CFO exercised options and sold US$3.7m worth of stock

Recent updates

At US$386, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Stryker Unveils Oculan Lighting Platform to Enhance Surgical Visualization and Inumination

Chairman exercised options and sold US$43m worth of stock

Stryker Launches Next Generation of SurgiCount+ to Help Improve the Standard of Care in Hospitals for Sponge Management and Blood Loss Assessment

Independent Director recently sold US$84m worth of stock

Independent Director notifies of intention to sell stock

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC

Treace Medical Concepts, Inc. Files Lawsuit Against Stryker Corporation and Its Subsidiary Wright Medical Technology, Inc

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker Corporation (NYSE:SYK) completed the acquisition of Vertos Medical Inc.

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker Corporation (NYSE:SYK) acquired NICO Corporation.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) completed the acquisition of Care.ai inc.

Stryker Corporation (NYSE:SYK) acquired The Osteotomy Truss System (OTS) and Ankle Truss System of 4WEB Inc.

We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt

Stryker Corporation (NYSE:SYK) entered into a definitive agreement to acquire Vertos Medical Inc.

Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't

Stryker Corporation (NYSE:SYK) agreed to acquire Care.ai inc.

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Second quarter dividend of US$0.80 announced

Independent Director notifies of intention to sell stock

Stryker Announces Launch of Pangea Plating System

Stryker: Wait For A Better Entry Point Post-Q2 Results

VP & CFO recently sold US$6.7m worth of stock

Stryker's Spine Guidance 5 Software Featuring Copilot Receives 510(K) Clearance from FDA

Second quarter 2024 earnings: EPS misses analyst expectations

Stryker Corporation (NYSE:SYK) completed the acquisition of Artelon, Inc.

Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?

VP & CFO exercised options and sold US$3.7m worth of stock

Stryker Corporation to Report Q2, 2024 Results on Jul 30, 2024

A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

Stryker: Margin Gains Should Drive Upside

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

VP & CFO recently sold US$3.3m worth of stock

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

First quarter dividend of US$0.80 announced

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024